Elevation Oncology, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Elevation Oncology's upcoming annual meeting on June 5, 2025, will include proposals for director elections, auditor ratification, and a potential reverse stock split.
DEF: Elevation Oncology Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
Elevation Oncology is asking stockholders to approve a reverse stock split to boost its share price and maintain its Nasdaq listing.
Elevation Oncology announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, with key voting items including the election of directors and ratification of the independent accounting firm.
Elevation Oncology will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, to vote on the election of directors and ratification of the company's independent accounting firm.